Lupus in the News: The latest data on the Phase III clinical studies of obinutuzumab (Gazyva) showed over 46% complete renal response in lupus nephritis – 13.4% better than standard therapies!

Link: https://ow.ly/puBa50V10Kx
Post image

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service